CULTURED SKIN FIBROBLASTS DERIVED FROM PATIENTS WITH MUCOLIPIDOSIS-4 ARE AUTOFLUORESCENT

被引:38
作者
GOLDIN, E [1 ]
BLANCHETTEMACKIE, EJ [1 ]
DWYER, NK [1 ]
PENTCHEV, PG [1 ]
BRADY, RO [1 ]
机构
[1] NIDDKD,BETHESDA,MD 20892
关键词
D O I
10.1203/00006450-199506000-00003
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Mucolipidosis 4 (ML4) is an autosomal recessive disorder with both lipid and mucopolysaccharide storage. The disease is characterized by severe visual impairment and psychomotor retardation. In our effort to find a phenotypic marker for ML4 fibroblasts, living cells were stained with fluorescent compounds. The staining pattern in cells was complicated by auto-fluorescence. A careful study revealed that auto-fluorescence by itself was a sufficient marker for viable ML4 fibroblasts. ML4 cells in cultures obtained from four unrelated patients contain auto-fluorescent material. Auto-fluorescence was noted over a wide range of excitation wavelengths from similar to 365 to similar to 546 nn. The most intense fluorescence was observed in the lower wavelength range. Cultured fibroblasts from normal individuals or obligate ML4 heterozygotes did not fluoresce under adequately controlled culture conditions. High passage number or inadequate feeding caused a small proportion of fibroblasts obtained from normal individuals to auto-fluoresce. The auto-fluorescent material co-localized with phase-dense inclusion bodies, shown to be lysosomes by staining with LAMP-ab. These findings imply that fluorescence may relate to the specific compound(s) stored in the lysosomes. In a comparative study, neuronal ceroid lipofuscinosis fibroblasts were also fluorescent. Fibroblasts from other diseases such as Gaucher disease and glycogenosis type 2 did not show any fluorescence. These findings are currently used in our functional cloning strategy for determining the gene involved in ML4.
引用
收藏
页码:687 / 692
页数:6
相关论文
共 13 条
  • [1] Berman E.R., Livni N., Shapira E., Merin S., Levij I.S., Congenital corneal clouding with abnormal systemic storage bodies: A new variant of mucolipidosis, J Pediatr, 84, pp. 519-526, (1974)
  • [2] Amir N., Zlotogora J., Bach G., Mucolipidosis type 4: Clinical spectrum and natural history, Pediatrics, 79, pp. 953-959, (1987)
  • [3] O'brien J.S., Ganglioside sialidase deficiency (Mucolipidosis 4), The Metabolic Basis of Inherited Disease, pp. 1797-1806, (1989)
  • [4] Livni N., Legum C., Infrastructure of cultured fibroblasts in mucolipidosis type 4, Exp Cell Biol, 44, pp. 1-11, (1976)
  • [5] Kohn G., Livni N., Ornoy A., Sekeles E., Beyth Y., Legum C., Bach G., Cohen M.M., Prenatal diagnosis of mucolipidosis 4 by electron microscopy, J Pediatr, 90, pp. 62-66, (1977)
  • [6] Tellez-Nagel I., Rapin I., Iwamoto T., Johnson A.B., Norton W.T., Nitowsky H., Mucolipidosis 4 clinical, ultrastructural, histochemical, and chemical studies of a case, including a brain biopsy, Arch Neurol, 33, pp. 828-835, (1976)
  • [7] Ziegler M., Bach G., Internalization of exogenous gangliosides in cultured skin fibroblasts for the diagnosis of mucolipidosis 4, Clin Chim Acta, 157, pp. 183-190, (1986)
  • [8] Ziegler M., Bargal R., Suri B.M., Bach G., Mucolipidosis type 4: Accumulation of phospholipids and gangliosides in cultured amniotic cells. A tool for prenatal diagnosis, Prenat Diagn, 12, pp. 1037-1042, (1992)
  • [9] Mane S.M., Marzella L., Bainton D.F., Holt V., Cha Y., Hildreth J., August J.T., Purification and characterization of human lysosomal membrane glycoproteins, Arch Biochim Biophys, 268, pp. 360-378, (1989)
  • [10] Dyken P.R., Neuronal ceroid lipofuscinosis, The Practice of Pediatric Neurology, pp. 902-914, (1982)